<table border="single" frame="box" id="ID_64970620-22C2-426F-BDCA-232A1D766BE5" width="100%" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption id="ID_99C6308C-3C60-4C1D-A68C-77072B472B1C">Table 7.  Erosive Esophagitis Patient Healing Rates</caption>
<col></col>
<col></col>
<col></col>
<tfoot id="ID_79CB2154-5D0B-4DA1-8F84-6ACD5BACDE85">
<tr><td colspan="3">* All patients were permitted p.r.n. antacids for relief of pain.<br/>† p&lt;0.001 versus placebo.</td></tr>
</tfoot>
<tbody>
<tr id="ID_69CCDCB9-FC89-43E2-8C8E-A4899E18D645"><td align="left" rowspan="2" valign="top"></td><td align="center" colspan="2" valign="top">Healed/Evaluable</td></tr>
<tr id="ID_EEC058F1-C4F9-4A67-9523-0C5D17A77C37"><td align="center" valign="top">Placebo* n=229</td><td align="center" valign="top">Ranitidine 150 mg<br/>q.i.d.* n=215</td></tr>
<tr id="ID_737A0897-8E2A-413B-A1A6-57ACEB776740"><td align="center" valign="top"><paragraph>Week 4</paragraph><paragraph>Week 8</paragraph>Week 12</td><td align="center" valign="top"><paragraph>43/198 (22%)</paragraph><paragraph>63/176 (36%)</paragraph>92/159 (58%)</td><td align="center" valign="top"><paragraph>96/206 (47%)† </paragraph><paragraph>142/200 (71%)† </paragraph>162/192 (84%)† </td></tr>
</tbody>
</table>